Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs

Rating :
74/99  (View)

BSE: 532989 | NSE: BAFNAPH

90.55
4.30 (4.99%)
23-Oct-2020 | 3:40PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  90.55
  •  90.55
  •  81.95
  •  86.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  19185
  •  17.37
  •  90.55
  •  4.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 63.97
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 58.50
  • N/A
  • 1.21

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 92.64%
  • 0.00%
  • 6.23%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 1.13%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.33
  • -13.02
  • -3.44

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -20.00
  • -15.29
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -31.18
  • -51.47

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.24
  • 0.24
  • 0.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -6.39
  • -14.94
  • -13.56

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
7
-100%
13
0
0
11
13
-16%
12
9
31%
Expenses
0
10
-100%
9
0
0
11
12
-10%
12
9
38%
EBITDA
0
-3
-
4
0
0
0
1
-81%
0
0
-
EBIDTM
0%
-42%
32%
0%
2%
9%
-3%
2%
Other Income
0
0
-100%
-1
0
-
0
0
-90%
1
0
-
Interest
0
0
-100%
0
0
0
0
0
-
0
1
-92%
Depreciation
0
1
-100%
1
0
0
1
1
11%
1
1
-4%
PBT
0
-4
-
2
0
0
-22
0
-
-1
-1
-
Tax
0
-2
-
2
0
0
0
0
-
0
0
-20%
PAT
0
-2
-
1
0
0
-22
0
-
-1
-1
-
PATM
0%
-31%
5%
0%
-204%
0%
-5%
-14%
EPS
0.00
-0.90
-
0.26
0.00
0
-9.42
0.03
-
-0.25
-0.54
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
42
44
47
65
85
139
185
176
129
Net Sales Growth
-
-3%
-8%
-27%
-24%
-39%
-25%
5%
37%
 
Cost Of Goods Sold
-
16
24
33
50
63
78
125
122
86
Gross Profit
-
26
20
14
15
22
61
61
53
43
GP Margin
-
62%
45%
29%
24%
26%
44%
33%
30%
33%
Total Expenditure
-
41
57
82
71
85
115
162
153
110
Power & Fuel Cost
-
3
2
2
2
3
2
2
2
2
% Of Sales
-
6%
6%
5%
3%
3%
1%
1%
1%
1%
Employee Cost
-
10
9
7
7
7
11
14
11
6
% Of Sales
-
24%
21%
16%
10%
8%
8%
8%
6%
5%
Manufacturing Exp.
-
8
8
8
6
8
13
11
10
11
% Of Sales
-
19%
19%
18%
9%
10%
9%
6%
6%
9%
General & Admin Exp.
-
4
3
2
2
2
5
6
6
3
% Of Sales
-
8%
6%
4%
3%
3%
3%
3%
3%
3%
Selling & Distn. Exp.
-
0
1
2
1
0
3
3
2
1
% Of Sales
-
1%
2%
5%
2%
1%
2%
2%
1%
1%
Miscellaneous Exp.
-
0
10
27
3
1
4
2
0
1
% Of Sales
-
0%
22%
57%
4%
2%
3%
1%
0%
0%
EBITDA
-
1
-13
-35
-6
1
23
23
22
19
EBITDA Margin
-
3%
-30%
-74%
-9%
1%
17%
12%
13%
14%
Other Income
-
0
0
31
1
2
5
2
3
1
Interest
-
0
2
7
11
13
13
13
12
8
Depreciation
-
3
3
4
4
5
6
9
8
6
PBT
-
-2
-18
-15
-20
-15
9
2
5
6
Tax
-
0
1
2
-1
0
0
1
1
3
Tax Rate
-
0%
-6%
-15%
4%
1%
-2%
42%
27%
65%
PAT
-
-2
-20
-17
-19
-14
6
1
4
2
PAT before Minority Interest
-
-2
-19
-17
-19
-15
6
1
4
2
Minority Interest
-
0
-1
0
0
1
0
0
0
0
PAT Margin
-
-5%
-46%
-35%
-29%
-16%
4%
1%
2%
1%
PAT Growth
-
89%
-19%
12%
-36%
-327%
341%
-65%
114%
 
EPS
-
-0.92
-8.39
-7.06
-8.05
-5.92
2.61
0.59
1.67
0.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
51
19
38
43
58
72
69
67
64
Share Capital
2
24
24
19
19
19
19
19
18
Total Reserves
-7
-5
14
20
39
53
50
46
40
Non-Current Liabilities
3
30
41
55
40
16
31
32
33
Secured Loans
0
21
21
37
35
12
23
25
26
Unsecured Loans
3
2
2
2
0
0
0
0
0
Long Term Provisions
0
0
0
0
0
0
0
0
0
Current Liabilities
17
71
60
81
95
111
135
160
122
Trade Payables
13
40
29
24
38
42
42
79
58
Other Current Liabilities
5
8
8
14
10
12
8
4
4
Short Term Borrowings
0
23
23
43
45
57
85
75
59
Short Term Provisions
0
0
0
0
2
0
0
2
0
Total Liabilities
71
119
138
178
193
200
236
261
219
Net Block
35
37
45
49
53
55
69
73
76
Gross Block
74
73
80
80
80
77
92
90
88
Accumulated Depreciation
39
36
35
31
27
23
23
18
12
Non Current Assets
35
71
90
101
70
73
72
74
77
Capital Work in Progress
0
0
0
0
0
0
0
0
0
Non Current Investment
0
0
0
17
17
17
0
0
0
Long Term Loans & Adv.
0
33
44
35
0
0
0
0
0
Other Non Current Assets
0
1
1
1
0
1
3
2
1
Current Assets
36
48
49
77
122
127
156
179
137
Current Investments
0
0
0
0
0
0
0
0
0
Inventories
11
9
11
17
16
16
27
22
24
Sundry Debtors
6
25
24
54
68
89
98
92
84
Cash & Bank
8
3
3
3
3
3
3
21
2
Other Current Assets
10
6
5
3
35
20
29
44
26
Short Term Loans & Adv.
3
5
6
1
34
18
24
40
23
Net Current Assets
19
-22
-11
-4
27
16
21
19
15
Total Assets
71
119
138
178
193
200
236
261
219

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
-34
-2
-7
-1
1
11
2
37
29
PBT
-2
-18
-15
-20
-15
6
2
5
5
Adjustment
-19
5
-20
16
16
-27
20
17
10
Changes in Working Capital
-13
11
27
4
0
33
-21
15
15
Cash after chg. in Working capital
-34
-2
-7
-1
1
13
2
38
30
Interest Paid
0
0
0
0
0
0
0
0
0
Tax Paid
0
0
0
0
0
-2
0
-1
-1
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
33
15
38
-5
0
60
-7
-6
-38
Net Fixed Assets
-1
0
0
0
-2
15
-2
-2
Net Investments
1
0
17
0
0
-17
0
0
Others
33
16
21
-5
2
62
-5
-4
Cash from Financing Activity
7
-14
-31
6
-1
-71
-13
-12
-1
Net Cash Inflow / Outflow
6
0
0
0
0
0
-18
19
-9
Opening Cash & Equivalents
3
3
3
3
3
3
21
2
12
Closing Cash & Equivalent
8
3
3
3
3
3
3
21
2

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
-18
8
16
21
31
38
33
30
29
ROA
-2%
-15%
-11%
-10%
-8%
3%
1%
2%
1%
ROE
-25%
-68%
-44%
-41%
-24%
9%
2%
7%
4%
ROCE
-3%
-22%
-7%
-7%
-2%
13%
10%
11%
10%
Fixed Asset Turnover
0.58
0.57
0.59
0.83
1.10
1.65
2.03
1.98
1.47
Receivable days
133
205
302
335
331
243
186
181
236
Inventory Days
89
83
106
91
69
57
49
47
67
Payable days
221
261
175
155
168
144
133
160
181
Cash Conversion Cycle
0
28
233
271
232
156
102
68
122
Total Debt/Equity
-0.71
2.43
1.23
2.13
1.41
0.96
1.76
1.76
1.62
Interest Cover
-19
-8
-1
-1
0
1
1
1
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.